ATE465413T1 - Verwendung von adam 12 zur diagnose von präeklampsie - Google Patents
Verwendung von adam 12 zur diagnose von präeklampsieInfo
- Publication number
- ATE465413T1 ATE465413T1 AT04790475T AT04790475T ATE465413T1 AT E465413 T1 ATE465413 T1 AT E465413T1 AT 04790475 T AT04790475 T AT 04790475T AT 04790475 T AT04790475 T AT 04790475T AT E465413 T1 ATE465413 T1 AT E465413T1
- Authority
- AT
- Austria
- Prior art keywords
- adam
- preeclampsia
- gene products
- diagnose preeclampsia
- diagnose
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Biophysics (AREA)
- Gynecology & Obstetrics (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03023815A EP1524523A1 (de) | 2003-10-17 | 2003-10-17 | Verwendung von ADAM 12 zur Diagnose und Behandlung von Preeclampsia |
| PCT/EP2004/011632 WO2005040831A1 (en) | 2003-10-17 | 2004-10-15 | Use of adam 12 for diagnosis and therapy of preeclampsia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE465413T1 true ATE465413T1 (de) | 2010-05-15 |
Family
ID=34354513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04790475T ATE465413T1 (de) | 2003-10-17 | 2004-10-15 | Verwendung von adam 12 zur diagnose von präeklampsie |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7842464B2 (de) |
| EP (2) | EP1524523A1 (de) |
| AT (1) | ATE465413T1 (de) |
| DE (1) | DE602004026771D1 (de) |
| DK (1) | DK1692517T3 (de) |
| WO (1) | WO2005040831A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2175277B1 (de) | 2004-05-19 | 2013-09-04 | Københavns Universitet | ADAM12 als Marker für Down-Syndrom im 2. Trimenon |
| GB0413688D0 (en) * | 2004-06-18 | 2004-07-21 | Novartis Forschungsstiftung | Analysis of methylated nucleic acid |
| CA2601735C (en) * | 2005-03-18 | 2015-10-06 | The Chinese University Of Hong Kong | Markers for prenatal diagnosis and monitoring of trisomy 21 |
| ITTO20050221A1 (it) | 2005-04-04 | 2006-10-05 | St Microelectronics Srl | Procedimento e sistema per la correzione degli errori a raffica nelle reti di comunicazione, rete e prodotto informatico relativi |
| WO2007030889A1 (en) * | 2005-09-15 | 2007-03-22 | Victor Voroteliak | Method of diagnosing pre-eclampsia |
| US20090274619A1 (en) * | 2006-01-26 | 2009-11-05 | George Coukos | Tumor vasculature markers and methods of use therof |
| WO2008119882A2 (en) * | 2007-03-30 | 2008-10-09 | Wallac Oy | Screening methods based on human adam12 polypeptide and binding agents thereof |
| CN110208540B (zh) * | 2008-10-31 | 2024-02-09 | 耶鲁大学 | 子痫前期检测和治疗的方法和组合物 |
| RU2487657C1 (ru) * | 2012-03-01 | 2013-07-20 | Федеральное государственное бюджетное учреждение "Научный центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения и социального развития Российской Федерации" | Способ морфологической диагностики преэклампсии |
| US9460402B2 (en) * | 2013-12-27 | 2016-10-04 | International Business Machines Corporation | Condensing hierarchical data |
| US9582566B2 (en) | 2013-12-27 | 2017-02-28 | International Business Machines Corporation | Condensing hierarchical data |
| RU2578425C2 (ru) * | 2014-05-07 | 2016-03-27 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" | Способ прогнозирования риска развития преэклампсии |
| CN108717123A (zh) * | 2018-04-25 | 2018-10-30 | 卢英 | 一种联合检测sFlt-1/PLGF和HLA-G检测先兆子痫的方法 |
| CN112946299B (zh) * | 2021-01-29 | 2022-11-29 | 暨南大学 | 定量ftl的产品在制备子痫前期诊断工具中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1250257A1 (ru) * | 1985-02-27 | 1986-08-15 | 2-Й Московский Ордена Ленина Государственный Медицинский Институт Им.Н.И.Пирогова | Способ прогнозировани патологического течени беременности |
| US5744101A (en) * | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US6248546B1 (en) * | 1998-03-09 | 2001-06-19 | Diagnostic Systems Laboratories, Inc. | Assay of IGFBP complex |
| US20030170627A1 (en) * | 2000-11-27 | 2003-09-11 | Walker Michael G. | cDNAs co-expressed with placental steroid synthesis genes |
| JP2005515757A (ja) * | 2001-08-30 | 2005-06-02 | エモリー・ユニバーシティ | ミトコンドリア生物学発現アレイ |
| US20040002467A1 (en) * | 2002-06-29 | 2004-01-01 | Isis Pharmaceuticals Inc. | Antisense modulation of ADAM12 expression |
| EP2175277B1 (de) * | 2004-05-19 | 2013-09-04 | Københavns Universitet | ADAM12 als Marker für Down-Syndrom im 2. Trimenon |
| EP1797897A4 (de) * | 2004-08-03 | 2008-06-18 | Mochida Pharm Co Ltd | Medizinische zusammensetzung mit einem meltrin-antagonisten |
-
2003
- 2003-10-17 EP EP03023815A patent/EP1524523A1/de not_active Withdrawn
-
2004
- 2004-10-15 WO PCT/EP2004/011632 patent/WO2005040831A1/en not_active Ceased
- 2004-10-15 DE DE602004026771T patent/DE602004026771D1/de not_active Expired - Lifetime
- 2004-10-15 EP EP04790475A patent/EP1692517B1/de not_active Expired - Lifetime
- 2004-10-15 DK DK04790475.0T patent/DK1692517T3/da active
- 2004-10-15 US US10/576,266 patent/US7842464B2/en not_active Expired - Fee Related
- 2004-10-15 AT AT04790475T patent/ATE465413T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20070161548A1 (en) | 2007-07-12 |
| EP1692517B1 (de) | 2010-04-21 |
| WO2005040831A1 (en) | 2005-05-06 |
| EP1524523A1 (de) | 2005-04-20 |
| EP1692517A1 (de) | 2006-08-23 |
| DK1692517T3 (da) | 2011-09-12 |
| US7842464B2 (en) | 2010-11-30 |
| DE602004026771D1 (de) | 2010-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE465413T1 (de) | Verwendung von adam 12 zur diagnose von präeklampsie | |
| DE69126710D1 (de) | Oligonukleotide zur modulation der effekte von cytomegalovirusinfektionen | |
| DE69638183D1 (de) | Verwendung von nukleinsäureliganden in der durchflusszytometrie | |
| EP1049767A4 (de) | Transgenes kaninchen, das ein funktionelles menschliches lipoprotein exprimiert | |
| ATE289200T1 (de) | Oligonucleotidzusammenstellung und verfahren zur regulierung der protein b7 expression | |
| ATE244506T1 (de) | Oligonukleotidmodulation der expression von multiwirkstoff-resistenz -assoziiertem protein | |
| ATE209684T1 (de) | Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung | |
| PL1669367T3 (pl) | Peptydy, które mogą wiązać się z transformującym czynnikiem wzrostu beta 1 (TGF-BETA1) | |
| ATE399014T1 (de) | Nukleinsäuren zur behandlung von erkrankungen im zusammenhang mit hmgb1 | |
| EE200100472A (et) | Polüpeptiid, antikehad, lahustuv polüpeptiid, polü- või oligonukleotiid ja meetod diferentsiaalseltekspresseerunud DNA järjestuste spetsiifiliseks identifitseerimiseks | |
| DE60115349D1 (de) | Polymorphismen im Gen für den humanen organischen Anionentransporter C (OATP-C) | |
| ATE375389T1 (de) | Verfahren zur diagnose, prognose und behandlung von glaukom und verwandten erkrankungen | |
| ATE298246T1 (de) | Aktiviertes protein c zur behandlung von pankreatitis | |
| ATE521631T1 (de) | Verwendung von aimp2dx2 zur diagnose und behandlung von krebs | |
| WO2004096856A3 (en) | Secreted protein family | |
| HUP0402327A2 (hu) | Inzulinszerű növekedési faktort kötő 5-ös fehérje expressziójának antiszensz módosítása | |
| ATE431361T1 (de) | Verwendung vom transportergen oatp-c zur screening von testsubstanzen | |
| EP1472375A4 (de) | In kanzerösen mammazellen differentiell exprimierte genprodukte und ihre verwendungsverfahren | |
| EP1212455A4 (de) | Antisense modulation der expression des telomerwiederholungsbindungsfaktor 1 | |
| ATE496129T1 (de) | Von hla-klasse-ii-molekülen präsentierte ssx-2- peptide | |
| GB0423126D0 (en) | Protein | |
| DE69521281D1 (de) | Verfahren zur Herstellung von menschlichem oder humanem Matrilysin mittels rekombinanter DNA. | |
| DE602004028497D1 (de) | Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen | |
| DE59912771D1 (de) | Kombination von genen zur regulierung der blühinduktion bei nutz- und zierpflanzen | |
| DE50014417D1 (de) | Nukleinsäure, die für ein protein der ctage-familie kodiert, deren verwendung und herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |